Hacker News: hnsr

New comment by hnsr in "Google changes its search box"

hnsr — Tue, 19 May 2026 19:02:35 +0000

Yeah, I've also already seen this for at least ~2 months

New comment by hnsr in "GPT-5.4"

hnsr — Thu, 05 Mar 2026 21:08:32 +0000

> I've been using Codex for software development personally (I have a ChatGPT account), and I use Claude at work (since it is provided by my employer).

Exact same situation here. I've been using both extensively for the last month or so, but still don't really feel either of them is much better or worse. But I have not done large complex features with it yet, mostly just iterative work or small features.

I also feel I am probably being very (overly?) specific in my prompts compared to how other people around me use these agents, so maybe that 'masks' things

New comment by hnsr in "The Codex App"

hnsr — Mon, 02 Feb 2026 21:02:51 +0000

Do you use Claude Code, or do you use the models from some other tool?

I find it quite hard to hit the limits with Claude Code, but I have several colleagues complaining a lot about hitting limits and they use Cursor. Recently they also seem to be dealing with poor results (context rot?) a lot, which I haven't really encountered yet.

I wonder if Claude Code is doing something smart/special

New comment by hnsr in "HIMARS on Russian Radar - how does it get through?"

hnsr — Sun, 24 Jul 2022 23:09:50 +0000

Thanks, changed it to match the original title

HIMARS on Russian Radar - how does it get through?

hnsr — Sun, 24 Jul 2022 22:53:02 +0000

Article URL: https://www.youtube.com/watch?v=ceskPbDtTzY

Comments URL: https://news.ycombinator.com/item?id=32218611

Points: 4

# Comments: 2

New comment by hnsr in "Moderna raises 2021 vaccine output forecast to at least 600M doses"

hnsr — Mon, 04 Jan 2021 16:27:56 +0000

This could be wishful thinking, but it would not surprise me if these numbers will go up for many or all of the vaccines. If the numbers of doses we've heard so far are contractually agreed upon, I would make sense that the manufacturers erred on the safe side regarding the number of doses they promise to deliver.